Starling Oncology Inc provides oncology care services in community settings... Show more
Industry HospitalNursingManagement
A.I.dvisor tells us that STLN and AIRS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STLN and AIRS's prices will move in lockstep.
| Ticker / NAME | Correlation To STLN | 1D Price Change % | ||
|---|---|---|---|---|
| STLN | 100% | +1.53% | ||
| AIRS - STLN | 32% Poorly correlated | +9.26% | ||
| ARDT - STLN | 28% Poorly correlated | -0.19% | ||
| NUTX - STLN | 27% Poorly correlated | -1.38% | ||
| ASTH - STLN | 27% Poorly correlated | -9.02% | ||
| SRTA - STLN | 25% Poorly correlated | +3.07% | ||
More | ||||
Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved above the 0 level on September 14, 2026. You may want to consider a long position or call options on STLN as a result. In 66 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
The Moving Average Convergence Divergence (MACD) for STLN just turned positive on September 16, 2026. Looking at past instances where STLN's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
Following a +4.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where STLN advanced for three days, in 255 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
STLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. STLN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (238.755). P/E Ratio (0.000) is within average values for comparable stocks, (133.266). STLN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.654). STLN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.014). P/S Ratio (1.124) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.